Early diagnosis of single nucleotide polymorphism loci in the susceptibility gene BRCA2 not only allows early prevention, diagnosis, and treatment of patients with BRCA2-associated breast cancer but may also help identify new therapeutic targets at the genetic level, providing a scientific basis for individualized prevention and treatment of breast cancer and further guiding the diagnosis and treatment.[30]. The gene discussed is BRCA2; the disease is breast carcinoma.